The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Transcriptome Sequencing Market Research Report 2025
Synopsis
The global Transcriptome Sequencing market was valued at US$ 1925.5 million in 2023 and is anticipated to reach US$ 5532.8 million by 2030, witnessing a CAGR of 16.6% during the forecast period 2024-2030.
The key service providers of Transcriptome Sequencing in the world are Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Roche, Pacific Biosciences and Eurofins Scientific, among which the top five providers account for more than 70% of the market share, and Illumina is the largest service provider. The global transcriptome sequencing service providers are mainly distributed in North America, Europe, China and Japan, among which the market share of the top three regions is close to 80%. At present, North America is the largest service provider region. In terms of its service type, the growth rate of noncoding RNA is relatively fast. At present, the market share of coding RNA is high, close to 80%. In terms of its application, biomedicine is the largest application field, with a market share of more than 85%, followed by non-medical fields.
This report aims to provide a comprehensive presentation of the global market for Transcriptome Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transcriptome Sequencing.
Report Scope
The Transcriptome Sequencing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transcriptome Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transcriptome Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina
Thermo Fisher Scientific
Bio-Rad
Agilent Technologies
QIAGEN
Roche
Pacific Biosciences
Eurofins Scientific
Azenta
LabCorp
BGI Genomics
Zhijiang Biology
Novogene Co., Ltd
Macrogen
Tsingke Biotechnology Co., Ltd.
Segment by Type
Coding RNA
Noncoding RNA
Segment by Application
Biomedical Field
Non-medical Field
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transcriptome Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Transcriptome Sequencing market was valued at US$ 1925.5 million in 2023 and is anticipated to reach US$ 5532.8 million by 2030, witnessing a CAGR of 16.6% during the forecast period 2024-2030.
The key service providers of Transcriptome Sequencing in the world are Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Roche, Pacific Biosciences and Eurofins Scientific, among which the top five providers account for more than 70% of the market share, and Illumina is the largest service provider. The global transcriptome sequencing service providers are mainly distributed in North America, Europe, China and Japan, among which the market share of the top three regions is close to 80%. At present, North America is the largest service provider region. In terms of its service type, the growth rate of noncoding RNA is relatively fast. At present, the market share of coding RNA is high, close to 80%. In terms of its application, biomedicine is the largest application field, with a market share of more than 85%, followed by non-medical fields.
This report aims to provide a comprehensive presentation of the global market for Transcriptome Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transcriptome Sequencing.
Report Scope
The Transcriptome Sequencing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transcriptome Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transcriptome Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina
Thermo Fisher Scientific
Bio-Rad
Agilent Technologies
QIAGEN
Roche
Pacific Biosciences
Eurofins Scientific
Azenta
LabCorp
BGI Genomics
Zhijiang Biology
Novogene Co., Ltd
Macrogen
Tsingke Biotechnology Co., Ltd.
Segment by Type
Coding RNA
Noncoding RNA
Segment by Application
Biomedical Field
Non-medical Field
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transcriptome Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transcriptome Sequencing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Coding RNA
1.2.3 Noncoding RNA
1.3 Market by Application
1.3.1 Global Transcriptome Sequencing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biomedical Field
1.3.3 Non-medical Field
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transcriptome Sequencing Market Perspective (2019-2030)
2.2 Transcriptome Sequencing Growth Trends by Region
2.2.1 Global Transcriptome Sequencing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Transcriptome Sequencing Historic Market Size by Region (2019-2024)
2.2.3 Transcriptome Sequencing Forecasted Market Size by Region (2025-2030)
2.3 Transcriptome Sequencing Market Dynamics
2.3.1 Transcriptome Sequencing Industry Trends
2.3.2 Transcriptome Sequencing Market Drivers
2.3.3 Transcriptome Sequencing Market Challenges
2.3.4 Transcriptome Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transcriptome Sequencing Players by Revenue
3.1.1 Global Top Transcriptome Sequencing Players by Revenue (2019-2024)
3.1.2 Global Transcriptome Sequencing Revenue Market Share by Players (2019-2024)
3.2 Global Transcriptome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transcriptome Sequencing Revenue
3.4 Global Transcriptome Sequencing Market Concentration Ratio
3.4.1 Global Transcriptome Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transcriptome Sequencing Revenue in 2023
3.5 Transcriptome Sequencing Key Players Head office and Area Served
3.6 Key Players Transcriptome Sequencing Product Solution and Service
3.7 Date of Enter into Transcriptome Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transcriptome Sequencing Breakdown Data by Type
4.1 Global Transcriptome Sequencing Historic Market Size by Type (2019-2024)
4.2 Global Transcriptome Sequencing Forecasted Market Size by Type (2025-2030)
5 Transcriptome Sequencing Breakdown Data by Application
5.1 Global Transcriptome Sequencing Historic Market Size by Application (2019-2024)
5.2 Global Transcriptome Sequencing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Transcriptome Sequencing Market Size (2019-2030)
6.2 North America Transcriptome Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Transcriptome Sequencing Market Size by Country (2019-2024)
6.4 North America Transcriptome Sequencing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transcriptome Sequencing Market Size (2019-2030)
7.2 Europe Transcriptome Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Transcriptome Sequencing Market Size by Country (2019-2024)
7.4 Europe Transcriptome Sequencing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transcriptome Sequencing Market Size (2019-2030)
8.2 Asia-Pacific Transcriptome Sequencing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Transcriptome Sequencing Market Size by Region (2019-2024)
8.4 Asia-Pacific Transcriptome Sequencing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transcriptome Sequencing Market Size (2019-2030)
9.2 Latin America Transcriptome Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Transcriptome Sequencing Market Size by Country (2019-2024)
9.4 Latin America Transcriptome Sequencing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transcriptome Sequencing Market Size (2019-2030)
10.2 Middle East & Africa Transcriptome Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Transcriptome Sequencing Market Size by Country (2019-2024)
10.4 Middle East & Africa Transcriptome Sequencing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Transcriptome Sequencing Introduction
11.1.4 Illumina Revenue in Transcriptome Sequencing Business (2019-2024)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Transcriptome Sequencing Introduction
11.2.4 Thermo Fisher Scientific Revenue in Transcriptome Sequencing Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Bio-Rad
11.3.1 Bio-Rad Company Detail
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad Transcriptome Sequencing Introduction
11.3.4 Bio-Rad Revenue in Transcriptome Sequencing Business (2019-2024)
11.3.5 Bio-Rad Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Detail
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Transcriptome Sequencing Introduction
11.4.4 Agilent Technologies Revenue in Transcriptome Sequencing Business (2019-2024)
11.4.5 Agilent Technologies Recent Development
11.5 QIAGEN
11.5.1 QIAGEN Company Detail
11.5.2 QIAGEN Business Overview
11.5.3 QIAGEN Transcriptome Sequencing Introduction
11.5.4 QIAGEN Revenue in Transcriptome Sequencing Business (2019-2024)
11.5.5 QIAGEN Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Transcriptome Sequencing Introduction
11.6.4 Roche Revenue in Transcriptome Sequencing Business (2019-2024)
11.6.5 Roche Recent Development
11.7 Pacific Biosciences
11.7.1 Pacific Biosciences Company Detail
11.7.2 Pacific Biosciences Business Overview
11.7.3 Pacific Biosciences Transcriptome Sequencing Introduction
11.7.4 Pacific Biosciences Revenue in Transcriptome Sequencing Business (2019-2024)
11.7.5 Pacific Biosciences Recent Development
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Detail
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific Transcriptome Sequencing Introduction
11.8.4 Eurofins Scientific Revenue in Transcriptome Sequencing Business (2019-2024)
11.8.5 Eurofins Scientific Recent Development
11.9 Azenta
11.9.1 Azenta Company Detail
11.9.2 Azenta Business Overview
11.9.3 Azenta Transcriptome Sequencing Introduction
11.9.4 Azenta Revenue in Transcriptome Sequencing Business (2019-2024)
11.9.5 Azenta Recent Development
11.10 LabCorp
11.10.1 LabCorp Company Detail
11.10.2 LabCorp Business Overview
11.10.3 LabCorp Transcriptome Sequencing Introduction
11.10.4 LabCorp Revenue in Transcriptome Sequencing Business (2019-2024)
11.10.5 LabCorp Recent Development
11.11 BGI Genomics
11.11.1 BGI Genomics Company Detail
11.11.2 BGI Genomics Business Overview
11.11.3 BGI Genomics Transcriptome Sequencing Introduction
11.11.4 BGI Genomics Revenue in Transcriptome Sequencing Business (2019-2024)
11.11.5 BGI Genomics Recent Development
11.12 Zhijiang Biology
11.12.1 Zhijiang Biology Company Detail
11.12.2 Zhijiang Biology Business Overview
11.12.3 Zhijiang Biology Transcriptome Sequencing Introduction
11.12.4 Zhijiang Biology Revenue in Transcriptome Sequencing Business (2019-2024)
11.12.5 Zhijiang Biology Recent Development
11.13 Novogene Co., Ltd
11.13.1 Novogene Co., Ltd Company Detail
11.13.2 Novogene Co., Ltd Business Overview
11.13.3 Novogene Co., Ltd Transcriptome Sequencing Introduction
11.13.4 Novogene Co., Ltd Revenue in Transcriptome Sequencing Business (2019-2024)
11.13.5 Novogene Co., Ltd Recent Development
11.14 Macrogen
11.14.1 Macrogen Company Detail
11.14.2 Macrogen Business Overview
11.14.3 Macrogen Transcriptome Sequencing Introduction
11.14.4 Macrogen Revenue in Transcriptome Sequencing Business (2019-2024)
11.14.5 Macrogen Recent Development
11.15 Tsingke Biotechnology Co., Ltd.
11.15.1 Tsingke Biotechnology Co., Ltd. Company Detail
11.15.2 Tsingke Biotechnology Co., Ltd. Business Overview
11.15.3 Tsingke Biotechnology Co., Ltd. Transcriptome Sequencing Introduction
11.15.4 Tsingke Biotechnology Co., Ltd. Revenue in Transcriptome Sequencing Business (2019-2024)
11.15.5 Tsingke Biotechnology Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
